TY - BOOK PY - 2010 DA - 2010// TI - The path to universal coverage. Executive summary. The world health report ID - ref1 ER - TY - BOOK PY - 2015 DA - 2015// TI - Fiscal sustainability of health systems. bridging health and finance perspectives ID - ref2 ER - TY - BOOK AU - Peiró, M. PY - 2017 DA - 2017// TI - Funding the gap. El futuro del sistema sanitario: ¿será posible financiar el sistema y reducir las desigualdades en salud? ID - Peiró2017 ER - TY - STD TI - Sánchez-Martínez, F.I., Méndez-Martínez, I., Martínez-Pérez, J.E., Abellá Perpiñán, J.M. El sistema sanitario público en España y sus comunidades autónomas. Sostenibilidad y reformas. 2013. https://www.fbbva.es/wp-content/uploads/2017/05/dat/DE_2013_IVIE_sistema_sanitario.pdf. Accessed 15 Jan 2018. UR - https://www.fbbva.es/wp-content/uploads/2017/05/dat/DE_2013_IVIE_sistema_sanitario.pdf ID - ref4 ER - TY - STD TI - Soto-Alvarez J. Evaluación Económica de Medicamentos y Tecnologías Sanitarias: Principios, Métodos y Aplicaciones en Política Sanitaria. Springer SBM Spain; 2012. p. 9–325. ID - ref5 ER - TY - JOUR AU - Mousnad, M. A. AU - Shafie, A. A. AU - Ibrahim, M. I. PY - 2014 DA - 2014// TI - Systematic review of factors affecting pharmaceutical expenditures JO - Health Policy VL - 16 UR - https://doi.org/10.1016/j.healthpol.2014.03.010 DO - 10.1016/j.healthpol.2014.03.010 ID - Mousnad2014 ER - TY - JOUR AU - Pearce, M. J. AU - Begg, E. J. PY - 1992 DA - 1992// TI - A review of limited lists and formularies: are they cost-effective? JO - Pharmacoeconomics. VL - 1 UR - https://doi.org/10.2165/00019053-199201030-00006 DO - 10.2165/00019053-199201030-00006 ID - Pearce1992 ER - TY - JOUR AU - Spurling, G. K. AU - Mansfield, P. R. AU - Montogomery, B. D. AU - Lexchin, J. AU - Doust, J. AU - Othman, N. PY - 2010 DA - 2010// TI - Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review JO - PLoS Med VL - 19 ID - Spurling2010 ER - TY - JOUR AU - Robertson, J. AU - Fryer, J. L. AU - O’Connell, D. L. AU - Sprogis, A. AU - Henry, D. A. PY - 2011 DA - 2011// TI - The impact of specialists on prescribing by general practitioners JO - Med J VL - 175 ID - Robertson2011 ER - TY - JOUR AU - Florentinus, S. R. AU - Heerdink, E. R. AU - Dijk, L. AU - Griens, F. AU - Groenewegen, P. P. AU - Leufkens, H. G. M. PY - 2009 DA - 2009// TI - Is new drug prescribing in primary care specialist induced? JO - BMC Health Serv Res VL - 9 UR - https://doi.org/10.1186/1472-6963-9-6 DO - 10.1186/1472-6963-9-6 ID - Florentinus2009 ER - TY - JOUR AU - Grimmsmann, T. AU - Schwabe, U. AU - Himmel, W. PY - 2007 DA - 2007// TI - The influence of hospitalisation on drug prescription in primary care—a large-scale follow-up study JO - Eur J Clin Pharmacol VL - 63 UR - https://doi.org/10.1007/s00228-007-0325-1 DO - 10.1007/s00228-007-0325-1 ID - Grimmsmann2007 ER - TY - JOUR PY - 2008 DA - 2008// TI - ASHP guidelines on the pharmacy and therapeutics committee and the formulary system JO - Am J Health-Syst Pharm VL - 65 UR - https://doi.org/10.2146/ajhp080086 DO - 10.2146/ajhp080086 ID - ref12 ER - TY - STD TI - World Health Organization. Managing access to medicines and health technologies. Part III: Management support systems. Hospital pharmacy management. 2012. Available from: http://apps.who.int/medicinedocs/documents/s19622en/s19622en.pdf. Accessed 20 Jun 2018. UR - http://apps.who.int/medicinedocs/documents/s19622en/s19622en.pdf ID - ref13 ER - TY - JOUR AU - Gallini, A. AU - Juillard-Condat, B. AU - Saux, M. C. AU - Taboulet, F. PY - 2011 DA - 2011// TI - Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes JO - Br J Clin Pharmacol VL - 72 UR - https://doi.org/10.1111/j.1365-2125.2011.03997.x DO - 10.1111/j.1365-2125.2011.03997.x ID - Gallini2011 ER - TY - JOUR AU - Plet, H. T. AU - Hallas, J. AU - Kjeldsen, L. J. PY - 2013 DA - 2013// TI - Adherence to hospital drug formularies and cost of drugs in hospitals in Denmark JO - Eur J Clin Pharmacol VL - 69 UR - https://doi.org/10.1007/s00228-013-1540-6 DO - 10.1007/s00228-013-1540-6 ID - Plet2013 ER - TY - JOUR AU - Plet, H. T. AU - Kjeldsen, L. J. AU - Christensen Rde, P. AU - Nielsen, G. S. AU - Hallas, J. PY - 2014 DA - 2014// TI - Do educational meetings and group detailing change adherence to drug formularies in hospitals? A cluster randomized controlled trial JO - Eur J Clin Pharmacol VL - 70 UR - https://doi.org/10.1007/s00228-013-1589-2 DO - 10.1007/s00228-013-1589-2 ID - Plet2014 ER - TY - JOUR AU - Fijn, R. AU - Lenderik, A. W. AU - Egberts, A. C. G. AU - Brouwers, J. R. B. J. AU - DenBerg, L. T. W. PY - 2001 DA - 2001// TI - Assessment of indicators for hospital drug formulary non adherence JO - Eur J Clin Pharmacol VL - 57 UR - https://doi.org/10.1007/s002280100358 DO - 10.1007/s002280100358 ID - Fijn2001 ER - TY - JOUR AU - Gustafsson, L. L. AU - Wettermark, B. AU - Godman, B. AU - Andersén-Karlsson, E. AU - Bergman, U. AU - Hasselström, J. PY - 2011 DA - 2011// TI - The ‘wise list’- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm JO - Basic Clin Pharmacol Toxicol VL - 108 UR - https://doi.org/10.1111/j.1742-7843.2011.00682.x DO - 10.1111/j.1742-7843.2011.00682.x ID - Gustafsson2011 ER - TY - JOUR AU - Gallini, A. AU - Legal, R. AU - Taboulet, F. PY - 2013 DA - 2013// TI - The influence of drug use in university hospitals on the pharmaceutical consumption in their surrounding communities JO - Br J Clin Pharmacol VL - 75 UR - https://doi.org/10.1111/j.1365-2125.2012.04455.x DO - 10.1111/j.1365-2125.2012.04455.x ID - Gallini2013 ER - TY - JOUR AU - Larsen, M. D. AU - Schou, M. AU - Kristiansen, A. S. AU - Hallas, J. PY - 2014 DA - 2014// TI - The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care JO - Eur J Clin Pharmacol VL - 70 UR - https://doi.org/10.1007/s00228-014-1681-2 DO - 10.1007/s00228-014-1681-2 ID - Larsen2014 ER - TY - JOUR AU - Vázquez-Mourelle, R. AU - Carracedo-Martinez, E. PY - 2017 DA - 2017// TI - The influence of changes in hospital drug formulary on the prescription of proton pump inhibitors JO - Farm Hosp VL - 41 ID - Vázquez-Mourelle2017 ER - TY - STD TI - Real Decreto 177/2014, de 21 de marzo, por el que se regula el sistema de precios de referencia y de agrupaciones homogéneas en el Sistema Nacional de Salud, y determinados sistemas de información en materia de financiación y precios de los medicamentos y productos sanitarios. 2014. Available from: https://www.boe.es/buscar/pdf/2014/BOE-A-2014-3189-consolidado.pdf. Accessed 17 May 2019. UR - https://www.boe.es/buscar/pdf/2014/BOE-A-2014-3189-consolidado.pdf ID - ref22 ER - TY - STD TI - Valentine KA, Hull RD. Therapeutic use of heparin and low molecular weight heparin. Uptodate. 2012. Available from: https://www.uptodate.com/contents/heparin-and-lmw-heparin-dosing-and-adverse-effects. Accessed 17 May 2019. UR - https://www.uptodate.com/contents/heparin-and-lmw-heparin-dosing-and-adverse-effects.%20Accessed%2017%20May%202019 ID - ref23 ER - TY - JOUR AU - Osakidetza PY - 2012 DA - 2012// TI - Heparinas de bajos peso molecular en atención primaria JO - Infac VL - 20 ID - Osakidetza2012 ER - TY - JOUR AU - Sruamsiri, R. AU - Wagner, A. K. AU - Ross-Degnan, D. AU - Lu, C. Y. AU - Dhippayom, T. AU - Ngorsuraches, S. PY - 2016 DA - 2016// TI - Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis JO - BMJ Open VL - 6 UR - https://doi.org/10.1136/bmjopen-2015-008671 DO - 10.1136/bmjopen-2015-008671 ID - Sruamsiri2016 ER - TY - JOUR AU - Kontopantelis, E. AU - Doran, T. AU - Springate, D. A. AU - Buchan, I. AU - Reeves, D. PY - 2015 DA - 2015// TI - Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis JO - BMJ VL - 350 UR - https://doi.org/10.1136/bmj.h2750 DO - 10.1136/bmj.h2750 ID - Kontopantelis2015 ER - TY - JOUR AU - Wagner, A. K. AU - Soumerai, S. B. AU - Zhang, F. AU - Ross-Degnan, D. PY - 2002 DA - 2002// TI - Segmented regression analysis of interrupted time series studies in medication use research JO - J Clin Pharm Ther VL - 27 UR - https://doi.org/10.1046/j.1365-2710.2002.00430.x DO - 10.1046/j.1365-2710.2002.00430.x ID - Wagner2002 ER - TY - STD TI - Gerencia de Gestión Integrada de Santiago de Compostela. https://xxisantiago.sergas.es/Paxinas/web.aspx?tipo=paxtab&idLista=3&idContido=183&migtab=174%3B183&idioma=es. Accessed 20 Sept 2018. UR - https://xxisantiago.sergas.es/Paxinas/web.aspx?tipo=paxtab&idLista=3&idContido=183&migtab=174%3B183&idioma=es ID - ref28 ER - TY - STD TI - Hospital universitario Lucus Augusti. 2017. https://xxilugo.sergas.es/Paxinas/web.aspx?tipo=paxtab&idLista=3&idContido=7&migtab=7&idioma=es . Accessed 20 Sept 2018. UR - https://xxilugo.sergas.es/Paxinas/web.aspx?tipo=paxtab&idLista=3&idContido=7&migtab=7&idioma=es ID - ref29 ER - TY - STD TI - World Health Organisation. WHO Collaborating Centre for Drug Statistics Methodology. https://www.whocc.no/. Accessed 20 Sept 2018. UR - https://www.whocc.no/ ID - ref30 ER - TY - STD TI - Agencia Española de Medicamentos y Productos Sanitarios. Centro de información de medicamentos. Encuentra tu medicamento aquí. https://www.aemps.gob.es/cima/publico/home.html. Accessed 20 Sept 2017. UR - https://www.aemps.gob.es/cima/publico/home.html ID - ref31 ER - TY - STD TI - World Health Organisation. WHO Collaborating Centre for Drug Statistics Methodology. Definition and general considerations. https://www.whocc.no/ddd/definition_and_general_considera/. Accessed 20 Sept 2017. UR - https://www.whocc.no/ddd/definition_and_general_considera/ ID - ref32 ER - TY - BOOK AU - Laporte, J. R. AU - Tognoni, G. PY - 2007 DA - 2007// TI - Los principios de epidemiología del medicamento. Masson Salvat Medicine ID - Laporte2007 ER - TY - JOUR AU - Linden, A. AU - Arbor, A. PY - 2015 DA - 2015// TI - Conducting interrupted time-series analysis for single and multiple group comparisons JO - Stata J VL - 15 UR - https://doi.org/10.1177/1536867X1501500208 DO - 10.1177/1536867X1501500208 ID - Linden2015 ER - TY - JOUR AU - Lapointe-Shaw, L. AU - Fischer, H. D. AU - Newman, A. AU - Baptiste, A. J. AU - Anderson, G. M. AU - Rochon, P. A. PY - 2012 DA - 2012// TI - Potential savings of harmonising hospital and community formularies for chronic disease medications initiated in hospital JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0039737 DO - 10.1371/journal.pone.0039737 ID - Lapointe-Shaw2012 ER - TY - JOUR AU - Dassner, A. M. AU - Girotto, J. E. PY - 2018 DA - 2018// TI - Evaluation of a second-sign process for antimicrobial prior authorization JO - J Pediatric Infect Dis Soc VL - 7 UR - https://doi.org/10.1093/jpids/pix015 DO - 10.1093/jpids/pix015 ID - Dassner2018 ER - TY - JOUR AU - Carracedo-Martínez, E. AU - Pia-Morandeira, A. AU - Figueiras, A. PY - 2012 DA - 2012// TI - Impact of a health safety warning and prior authorisation on the use of piroxicam: a time-series study JO - Pharmacoepidemiol Drug Saf VL - 21 UR - https://doi.org/10.1002/pds.2275 DO - 10.1002/pds.2275 ID - Carracedo-Martínez2012 ER - TY - JOUR AU - Chinitz, D. P. AU - Waitman, D. A. AU - Kahan, E. PY - 2006 DA - 2006// TI - When gatekeepers meet the sentinel: the impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community-based physicians JO - Br J Clin Pharmacol VL - 61 UR - https://doi.org/10.1111/j.1365-2125.2006.02577.x DO - 10.1111/j.1365-2125.2006.02577.x ID - Chinitz2006 ER - TY - JOUR AU - Godman, B. AU - Sakshaug, S. AU - Berg, C. AU - Wettermark, B. PY - 2011 DA - 2011// TI - Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs JO - Expert Rev Pharmacoecon Outcomes Res VL - 11 UR - https://doi.org/10.1586/erp.10.87 DO - 10.1586/erp.10.87 ID - Godman2011 ER - TY - JOUR AU - O’Connor, A. B. AU - Lang, V. J. AU - Quill, T. E. PY - 2005 DA - 2005// TI - Eliminating analgesic meperidine use with a supported formulary restriction JO - Am J Med VL - 118 UR - https://doi.org/10.1016/j.amjmed.2005.01.061 DO - 10.1016/j.amjmed.2005.01.061 ID - O’Connor2005 ER - TY - JOUR AU - Benner, K. W. AU - Durham, S. H. PY - 2011 DA - 2011// TI - Meperidine restriction in a pediatric hospital JO - J Pediatr Pharmacol Ther VL - 16 ID - Benner2011 ER - TY - STD TI - Generics ands biosimilars initiative. FDA approves first biosimilar enoxaparin sodium. 2016. http://www.gabionline.net/Biosimilars/General/Biosimilars-approved-in-Europe. Accessed 20 sept 2017. UR - http://www.gabionline.net/Biosimilars/General/Biosimilars-approved-in-Europe ID - ref42 ER - TY - STD TI - European Medicines Agency (EMA). Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP). 2016. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/07/news_detail_002571.jsp&mid=WC0b01ac058004d5c1.Accessed 20 Sept 2017. UR - http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/07/news_detail_002571.jsp&mid=WC0b01ac058004d5c1 ID - ref43 ER - TY - STD TI - European Medicines Agency (EMA). Committee for Medicinal Products for Human Use. Inhixa. 2016. http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004264/WC500210836.pdf. Accessed 20 Sept 2017. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004264/WC500210836.pdf ID - ref44 ER - TY - STD TI - World Health Organisation (WHO). Drug and therapeutics committees - A practical guide. 2003. http://apps.who.int/medicinedocs/pdf/s4882e/s4882e.pdf. Accessed 20 Sept 2017. UR - http://apps.who.int/medicinedocs/pdf/s4882e/s4882e.pdf ID - ref45 ER - TY - JOUR AU - Duran-Garcia, E. AU - Santos-Ramos, B. AU - Puigventos-Latorre, F. AU - Ortega, A. PY - 2011 DA - 2011// TI - Literature review on the structure and operation of Pharmacy and Therapeutics Committees JO - Int J Clin Pharm VL - 33 UR - https://doi.org/10.1007/s11096-011-9501-6 DO - 10.1007/s11096-011-9501-6 ID - Duran-Garcia2011 ER - TY - JOUR AU - Puigventós, F. AU - Santos-Ramos, B. AU - Ortega, A. AU - Durán-García, E. PY - 2010 DA - 2010// TI - Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals JO - Pharm World Sci VL - 32 UR - https://doi.org/10.1007/s11096-010-9435-4 DO - 10.1007/s11096-010-9435-4 ID - Puigventós2010 ER - TY - JOUR AU - Lopez Bernal, J. AU - Cummins, S. AU - Gasparrini, A. PY - 2018 DA - 2018// TI - The use of controls in interrupted time series studies of public health interventions JO - Int J Epidemiol VL - 47 UR - https://doi.org/10.1093/ije/dyy135 DO - 10.1093/ije/dyy135 ID - Lopez Bernal2018 ER - TY - JOUR AU - Soumerai, S. B. AU - Starr, D. AU - Majumdar, S. R. PY - 2015 DA - 2015// TI - How do you know which health care effectiveness research you can trust? JO - A guide to study design for the perplexed Prev Chronic Dis VL - 12 ID - Soumerai2015 ER -